Sartorius Stedim Biotech SA
OTC:SDMHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sartorius Stedim Biotech SA
OTC:SDMHF
|
FR |
|
F
|
Fortinet Inc
F:FO8
|
US |
|
Trigano SA
PAR:TRI
|
FR |
|
Sidomulyo Selaras Tbk PT
IDX:SDMU
|
ID |
|
Fraport AG Frankfurt Airport Services Worldwide
F:FRA
|
DE |
|
E
|
Eiffage SA
DUS:EF3
|
FR |
|
S
|
Swedish Orphan Biovitrum AB (publ)
XMUN:B6E
|
SE |
|
DBS Group Holdings Ltd
OTC:DBSDF
|
SG |
|
T
|
Trip.com Group Ltd
F:CLV
|
CN |
|
Grail Inc
F:NL0
|
US |
|
P
|
Pegasystems Inc
F:PEA
|
US |
|
Darktrace PLC
F:7TJ0
|
UK |
|
F
|
Frontline Ltd
NYSE:FRO
|
BM |
|
I
|
Isuzu Motors Ltd
DUS:ISU
|
JP |
|
B
|
Bombardier Inc
XHAM:BBDB
|
CA |
|
Shenzhou International Group Holdings Ltd
F:S6L
|
CN |
|
C
|
Commerzbank AG
SWB:ZZMS
|
DE |
|
J
|
Jana Small Finance Bank Ltd
NSE:JSFB
|
IN |
|
C
|
Caspian Sunrise PLC
SWB:RO1
|
UK |
|
F
|
Fluor Corp
F:FLU
|
US |
|
K
|
Kone Oyj
XMUN:KC4
|
FI |
|
QBE Insurance Group Ltd
ASX:QBE
|
AU |
|
P
|
Purepoint Uranium Group Inc
XMUN:P5X
|
CA |
|
Flame Acquisition Corp
NYSE:SOC
|
US |
Wall St Price Targets
SDMHF Price Targets Summary
Sartorius Stedim Biotech SA
According to Wall Street analysts, the average 1-year price target for SDMHF is 273.53 USD with a low forecast of 246.14 USD and a high forecast of 319.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SDMHF's stock price target?
Price Target
273.53
USD
According to Wall Street analysts, the average 1-year price target for SDMHF is 273.53 USD with a low forecast of 246.14 USD and a high forecast of 319.25 USD.
What is the Revenue forecast for Sartorius Stedim Biotech SA?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for Sartorius Stedim Biotech SA?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 5 years is 13%.
What is the Operating Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 17%.
What is the Pre-Tax Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
36%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 36%.
What is the Net Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 24%.
